High-Protein Diets for Treatment of Type 2 Diabetes Mellitus: A Systematic Review.


Journal

Advances in nutrition (Bethesda, Md.)
ISSN: 2156-5376
Titre abrégé: Adv Nutr
Pays: United States
ID NLM: 101540874

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 04 09 2018
revised: 02 11 2018
accepted: 02 01 2019
entrez: 16 7 2019
pubmed: 16 7 2019
medline: 21 5 2020
Statut: ppublish

Résumé

Diet has the potential to be a powerful and cost-effective tool for treatment of type 2 diabetes mellitus (T2D). High-protein diets have shown promise for this purpose. The objective of this systematic review was to evaluate whether high-protein diets improve glycemic outcomes in people with T2D. We conducted a systematic search of literature published prior to 1 February 2018 to find clinical studies of high-protein diet patterns for treatment of T2D in human participants. A high-protein diet was defined as a diet with protein content greater than that of a typical diet in the United States (>16% of total energy as protein). Studies were excluded if weight loss >5% occurred or if no glycemic outcomes were measured. A total of 21 independent articles met our criteria and were included. Most tested diets had a protein content of around 30% of total energy. Many studies supported the use of high-protein diets for patients with T2D, but were limited by small size (n = 8-32) and short duration (1-24 wk). Randomized controlled trials tended to be larger (n = 12-419) and longer (6 wk-2 y), and had mixed results, with many trials showing no difference between a high-protein diet and control. Many randomized controlled trials were limited by low compliance and high dropout rates >15%. There were no consistent beneficial or detrimental effects of high-protein diets on renal or cardiovascular outcomes. Evidence was insufficient to recommend 1 type of protein (plant or animal) over the other. Our review suggests that interventions to improve compliance with diet change over the long term may be equally important as specific macronutrient recommendations for treatment of T2D.

Identifiants

pubmed: 31305905
pii: S2161-8313(22)00405-7
doi: 10.1093/advances/nmz002
pmc: PMC6628842
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-633

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002492
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Informations de copyright

Copyright © American Society for Nutrition 2019.

Références

J Am Coll Nutr. 2017 May-Jun;36(4):295-305
pubmed: 28443785
Am J Clin Nutr. 2018 Aug 1;108(2):405-413
pubmed: 29931213
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Clin Nutr. 2010 Jun;64(6):595-602
pubmed: 20216558
Br J Nutr. 2008 Mar;99(3):511-9
pubmed: 17868489
J Endocrinol. 1970 Apr;46(4):445-51
pubmed: 5448583
Diabetes Care. 2003 Aug;26(8):2481-2
pubmed: 12882894
Diabetologia. 2012 Apr;55(4):905-14
pubmed: 22286528
Diabetes Care. 1984 Sep-Oct;7(5):465-70
pubmed: 6389060
J Am Diet Assoc. 2008 Jan;108(1):91-100
pubmed: 18155993
Diabetes Obes Metab. 2017 Jul;19(7):944-952
pubmed: 28181738
Diabetes Care. 2002 Apr;25(4):645-51
pubmed: 11919119
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Nutr Metab (Lond). 2006 Mar 23;3:16
pubmed: 16556307
Diabetes Care. 2018 Jan;41(Suppl 1):S38-S50
pubmed: 29222375
Diabetes Care. 2015 Jun;38(6):1161-72
pubmed: 25998297
Nutr Metab (Lond). 2010 Jul 29;7:64
pubmed: 20670414
J Am Diet Assoc. 1989 Aug;89(8):1076-86
pubmed: 2547860
Front Endocrinol (Lausanne). 2018 Aug 06;9:443
pubmed: 30127768
Annu Rev Nutr. 2017 Aug 21;37:347-369
pubmed: 28637384
Am J Clin Nutr. 2008 May;87(5):1571S-1575S
pubmed: 18469290
Diabetologia. 2011 Apr;54(4):731-40
pubmed: 21246185
Exp Clin Endocrinol Diabetes. 2013 May;121(5):286-94
pubmed: 23674159
J Hum Nutr Diet. 2017 Aug;30(4):479-489
pubmed: 28150347
Metabolism. 1988 Nov;37(11):1081-8
pubmed: 3054432
Prim Care Diabetes. 2014 Dec;8(4):308-14
pubmed: 24656509
J Am Coll Nutr. 1992 Dec;11(6):701-6
pubmed: 1460185
J Acad Nutr Diet. 2015 Sep;115(9):1447-63
pubmed: 25935570
Nutr J. 2011 Jul 14;10:74
pubmed: 21756320
Metabolism. 1977 Aug;26(8):911-9
pubmed: 875735
Diabetes Care. 2002 Aug;25(8):1277-82
pubmed: 12145221
Diabetes. 2004 Sep;53(9):2375-82
pubmed: 15331548
Diabetologia. 2004 Oct;47(10):1677-86
pubmed: 15480538
Diabetes Care. 2012 Feb;35(2):434-45
pubmed: 22275443
Diabetes Care. 2014 Jan;37 Suppl 1:S120-43
pubmed: 24357208
J Am Diet Assoc. 2005 Apr;105(4):573-80
pubmed: 15800559
Hum Nutr Appl Nutr. 1983 Jun;37 A(3):226-30
pubmed: 6347984
Am J Clin Nutr. 2003 Oct;78(4):734-41
pubmed: 14522731
Metabolism. 1980 May;29(5):421-8
pubmed: 6990178
Diabetologia. 1993 Sep;36(9):829-34
pubmed: 8405754
Am J Clin Nutr. 2005 Jul;82(1 Suppl):242S-247S
pubmed: 16002829
J Clin Endocrinol Metab. 2001 Mar;86(3):1040-7
pubmed: 11238483

Auteurs

Samar Malaeb (S)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN.

Caitlin Bakker (C)

University of Minnesota Health Sciences Libraries, Minneapolis, MN.

Lisa S Chow (LS)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN.

Anne E Bantle (AE)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH